
Revolving door redux: The DEA’s recently departed No. 2 returns to a Big Pharma consulting firm
By JOSHUA GOODMAN and JIM MUSTIAN Associated Press WASHINGTON (AP) — Washington’s revolving door kept spinning this week as the Drug Enforcement…
Continue Reading